Literature DB >> 30206735

Roles of SIRT1/FoxO1/SREBP-1 in the development of progestin resistance in endometrial cancer.

Yilin Wang1, Lili Zhang2, Xiaoxia Che1, Wenzhi Li1, Zhiming Liu1, Jie Jiang3.   

Abstract

PURPOSE: The prevalence of endometrial cancer (EC) is increasing worldwide. Progestin therapy is effective for both early stage EC patients who require preserving fertility and advanced or recurrent patients. Progestin resistance resulting from downregulation of progesterone receptor (PR) remains a major problem, and its mechanism is currently unclear. It was demonstrated that Sirtuin 1 (SIRT1), forkhead transcription factor 1 (FoxO1) and sterol regulatory element binding protein-1 (SREBP-1) may act as a pathway and play crucial roles in the development of EC in our previous studies. In the present study, we investigated the effect on the development of progestin resistance and the relationship with PR of SIRT1/FoxO1/SREBP-1.
METHODS: A progestin-resistant Ishikawa cell line was established in the stimulation and selection of medroxyprogesterone acetate (MPA), and the resistance was analyzed by MTT assay, flow cytometry, and Transwell invasion assay. qRT-PCR and western blotting were conducted to detect the expression of SIRT1, FoxO1, SREBP-1 and PR. SIRT1 knockdown progestin-resistant cells were established by lentiviral transduction.
RESULTS: The new progestin-resistant cell line presented sufficient resistance to MPA in aspects of proliferation, distribution of cell cycle and apoptosis compared with original Ishikawa cells. Besides, the invasion capability of progestin-resistant cells was observably increased. In both protein and mRNA levels, SIRT1 and SREBP-1 were upregulated in progestin-resistant cells, while PR and FoxO1 were downregulated. SIRT1 was knocked down by lentivirus transfection in progestin-resistant cells, resulting in upregulation of PR, FoxO1 and downregulation of SREBP-1, thereby SIRT1 knockdown cells were more sensitive to MPA compared with progestin-resistant cells.
CONCLUSION: SIRT1/FoxO1/SREBP-1 act as a pathway targeting PR and involve in the development of progestin resistance in Ishikawa cells.

Entities:  

Keywords:  Endometrial cancer; FoxO1; Progestin resistance; SIRT1; SREBP-1

Mesh:

Substances:

Year:  2018        PMID: 30206735     DOI: 10.1007/s00404-018-4893-3

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  13 in total

1.  A Novel Small-Molecule Inhibitor of SREBP-1 Based on Natural Product Monomers Upregulates the Sensitivity of Lung Squamous Cell Carcinoma Cells to Antitumor Drugs.

Authors:  De-Bin Ma; Xing-Yu Liu; Hui Jia; Yingshi Zhang; Qiyu Jiang; Huiwei Sun; Xiaojuan Li; Fang Sun; Yantao Chai; Fan Feng; Lei Liu
Journal:  Front Pharmacol       Date:  2022-05-18       Impact factor: 5.988

2.  Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma.

Authors:  Xiaohong Ma; Tianyi Zhao; Hong Yan; Kui Guo; Zhiming Liu; Lina Wei; Wei Lu; Chunping Qiu; Jie Jiang
Journal:  Cell Death Dis       Date:  2021-05-26       Impact factor: 8.469

3.  SIRT1 and gynecological malignancies (Review).

Authors:  Jiayu Chen; Houzao Chen; Lingya Pan
Journal:  Oncol Rep       Date:  2021-03-02       Impact factor: 3.906

4.  SIRT1 inhibits hepatocellular carcinoma metastasis by promoting M1 macrophage polarization via NF-κB pathway.

Authors:  Bei Zhou; Yun Yang; Cuiping Li
Journal:  Onco Targets Ther       Date:  2019-04-04       Impact factor: 4.147

5.  Comprehensive bioinformatics analysis of acquired progesterone resistance in endometrial cancer cell line.

Authors:  Wenzhi Li; Shufen Wang; Chunping Qiu; Zhiming Liu; Qing Zhou; Deshui Kong; Xiaohong Ma; Jie Jiang
Journal:  J Transl Med       Date:  2019-02-27       Impact factor: 5.531

6.  DACH1 suppresses epithelial to mesenchymal transition (EMT) through Notch1 pathway and reverses progestin resistance in endometrial carcinoma.

Authors:  Qing Zhou; Wenzhi Li; Deshui Kong; Zhiming Liu; Zhengzheng Shi; Xiaohong Ma; Yongmei Li; Jie Jiang
Journal:  Cancer Med       Date:  2019-06-18       Impact factor: 4.452

7.  Panax notoginseng saponins reverse P-gp-mediated steroid resistance in lupus: involvement in the suppression of the SIRT1/FoxO1/MDR1 signalling pathway in lymphocytes.

Authors:  Feng Pan; Yue-Jin Li; Ying Lu
Journal:  BMC Complement Med Ther       Date:  2022-01-12

8.  The Mutual Inhibition of FoxO1 and SREBP-1c Regulated the Progression of Hepatoblastoma by Regulating Fatty Acid Metabolism.

Authors:  Yu Hu; Hongyan Zai; Wei Jiang; Zhenglin Ou; Yuanbing Yao; Qin Zhu
Journal:  Mediators Inflamm       Date:  2021-09-08       Impact factor: 4.711

Review 9.  Deacetylation of Transcription Factors in Carcinogenesis.

Authors:  Marta Halasa; Kamila Adamczuk; Grzegorz Adamczuk; Syeda Afshan; Andrzej Stepulak; Marek Cybulski; Anna Wawruszak
Journal:  Int J Mol Sci       Date:  2021-10-30       Impact factor: 5.923

10.  Hsa_Circ_0001860 Promotes Smad7 to Enhance MPA Resistance in Endometrial Cancer via miR-520h.

Authors:  Shuang Yuan; Panchan Zheng; Xiao Sun; Judan Zeng; Wenjiao Cao; Wuyuan Gao; Yudong Wang; Lihua Wang
Journal:  Front Cell Dev Biol       Date:  2021-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.